Investors Research Corp’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$158K Hold
2,260
0.03% 331
2025
Q1
$166K Buy
2,260
+240
+12% +$17.6K 0.04% 316
2024
Q4
$132K Hold
2,020
0.03% 354
2024
Q3
$157K Hold
2,020
0.03% 340
2024
Q2
$158K Sell
2,020
-1,153
-36% -$89.9K 0.04% 339
2024
Q1
$215K Sell
3,173
-784
-20% -$53.1K 0.05% 312
2023
Q4
$267K Buy
3,957
+384
+11% +$25.9K 0.06% 285
2023
Q3
$242K Hold
3,573
0.06% 296
2023
Q2
$256K Sell
3,573
-2,400
-40% -$172K 0.06% 298
2023
Q1
$415K Sell
5,973
-700
-10% -$48.6K 0.11% 235
2022
Q4
$452K Hold
6,673
0.12% 219
2022
Q3
$366K Buy
6,673
+29
+0.4% +$1.59K 0.11% 226
2022
Q2
$439K Hold
6,644
0.13% 213
2022
Q1
$441K Hold
6,644
0.12% 210
2021
Q4
$387K Hold
6,644
0.12% 215
2021
Q3
$399K Buy
6,644
+644
+11% +$38.7K 0.13% 204
2021
Q2
$359K Hold
6,000
0.12% 219
2021
Q1
$298K Hold
6,000
0.11% 245
2020
Q4
$300K Hold
6,000
0.12% 241
2020
Q3
$329K Hold
6,000
0.16% 190
2020
Q2
$317K Hold
6,000
0.16% 200
2020
Q1
$268K Hold
6,000
0.17% 210
2019
Q4
$299K Sell
6,000
-1,666
-22% -$83K 0.14% 230
2019
Q3
$342K Hold
7,666
0.17% 182
2019
Q2
$316K Sell
7,666
-300
-4% -$12.4K 0.17% 187
2019
Q1
$322K Hold
7,966
0.17% 180
2018
Q4
$303K Hold
7,966
0.21% 179
2018
Q3
$315K Hold
7,966
0.18% 200
2018
Q2
$280K Hold
7,966
0.16% 217
2018
Q1
$279K Hold
7,966
0.17% 225
2017
Q4
$276K Buy
+7,966
New +$276K 0.17% 217